Overview
State Medicaid programs are undergoing fundamental transition. States are reshaping their Medicaid programs and their entire health systems by developing new models of providing benefits. The federal government continues
to place Medicaid reform at the top of its agenda as it seeks broader cost savings. With the advent of the new Medicare
prescription drug benefit, states must maneuver real-time challenges in managing their beneficiaries' health, while adjusting to the benefit's new financial requirements for states. These changes affect all health care stakeholders who must develop new policy and commercial strategies in response to the new evolution in Medicaid.
Join national thought leaders for the National Medicaid Congress, www.MedicaidCongress.com, June 4 - 6, 2006, in Washington, DC. This engaging three-day session will address critical questions about emerging Medicaid reform models, the expanded role of Medicaid managed care, new federal and state strategies to manage costs, the impact of the Medicare prescription drug benefit, and the future of Medicaid long-term care.
Learning Objectives
- To identify the leading state reform models that will drive the national Medicaid reform debate
- To analyze the leading factors driving Medicaid costs and the leading options for reform from the perspectives of Congress, CMS, states, and the federal Medicaid Commission
- To assess the impact of the Medicare prescription drug benefit on dual eligible beneficiaries and state Medicaid programs
- To describe the impact of recent federal changes to Medicaid pharmacy reimbursements, cost-sharing, and Medicaid benefit design
- To explore emerging state strategies to reduce costs for health care services and to improve quality through health information technology and other initiatives
- To examine emerging federal and state strategies to reform Medicaid's long-term care benefits and their impact on service quality and patient care
Who Should Attend
- Generic Pharmaceutical Manufacturers
- Pharmaceutical Manufacturers
- Policy Makers
- Health Services Researchers and Academics
- Pharmaceutical and Health Care Executives and
- Board Members
- State Legislators
- State Medicaid and Pharmacy Directors
- SPAP Directors
- Patient Advocates
- Medicaid Managed Care Directors
- Health Plan, Health System and Physician Organizations
- Medical Directors
- Physicians
- Pharmacists
- Purchasers, including Private Employers and Public Purchasers
- Pharmacy Benefit Management Companies
- Health Plans and Health Insurers
- Wholesale, Retail, Mail Order and Internet Pharmacies
- Health Care Attorneys and In-house Counsel
- Pharmaceutical Consultants
- Investment Bankers
- Venture Capitalists
|
